Nanoliposome-encapsulated ellagic acid prevents cyclophosphamide-induced rat liver damage
Volume: 458, Issue: 1-2, Pages: 185 - 195
Published: Apr 19, 2019
Abstract
In this study, we aimed to evaluate whether the encapsulation of ellagic acid (EA) into nanoliposomes would improve its potential in preventing cyclophosphamide-induced liver damage. Stability and antioxidative potential of free and encapsulated EA were determined. Experimental study conducted in vivo included ten groups of rats treated with cyclophosphamide and ellagic acid in its free and encapsulated form during 5 days. The protective effect...
Paper Details
Title
Nanoliposome-encapsulated ellagic acid prevents cyclophosphamide-induced rat liver damage
Published Date
Apr 19, 2019
Volume
458
Issue
1-2
Pages
185 - 195
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History